Zobrazeno 1 - 10
of 139
pro vyhledávání: '"H Lorberboum-Galski"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Journal of Immunology. 153:2497-2505
IL-2-PE40 is a chimeric protein composed of human IL-2 genetically fused to the amino terminus of a modified form of Pseudomonas exotoxin lacking its cell recognition domain. The immunosuppressive efficacy of IL-2-PE40 was demonstrated in several exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bdb36134d1f5b001ed2fe2468a4e186
https://doi.org/10.4049/jimmunol.153.6.2497
https://doi.org/10.4049/jimmunol.153.6.2497
Autor:
R W Kozak, H Lorberboum-Galski, L Jones, R K Puri, M C Willingham, T Malek, D J Fitzgerald, T A Waldmann, I Pastan
Publikováno v:
The Journal of Immunology. 145:2766-2771
A number of different immunotherapeutic reagents are currently being developed to target IL-2R for the treatment of leukemia, graft rejection, and certain autoimmune diseases. Previously, we have shown that IL-2-PE40, a chimeric protein composed of h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f7ae3c7c1fb822d9c157366aba23ad6
https://doi.org/10.4049/jimmunol.145.8.2766
https://doi.org/10.4049/jimmunol.145.8.2766
Autor:
Thomas A. Waldmann, Maurice K. Gately, Richard E. Clark, Desmond J. Fitzgerald, Vijay K. Chaudhary, H. Lorberboum-Galski, P. S. Brown, R. J. Garsia, Ira Pastan
Publikováno v:
Journal of Biological Chemistry. 265:16311-16317
To produce a molecule that will kill activated T cells as well as lymphomas and leukemias expressing interleukin 2 (IL2) receptors, we have created a recombinant chimeric protein in which IL2 is attached in peptide linkage to a truncated mutant form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::560d0a0e2703303a1c9e6f393a29edd6
https://doi.org/10.1016/s0021-9258(17)46224-7
https://doi.org/10.1016/s0021-9258(17)46224-7
Autor:
Y, Azar, H, Lorberboum-Galski
Publikováno v:
Apoptosis : an international journal on programmed cell death. 5(6)
In recent years chimeric proteins carrying bacterial toxins as their killing moiety, have been developed to selectively recognize and kill cell populations expressing speciific receptors. The involvement of Gonadotropin releasing hormone (GnRH) has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8ffdeeb04edb67a5fad558b812779387
https://pubmed.ncbi.nlm.nih.gov/11303912
https://pubmed.ncbi.nlm.nih.gov/11303912
Autor:
Robert Lafyatis, Ira Pastan, John Case, David J. FitzGerald, Ronald L. Wilder, H. Lorberboum-Galski
Publikováno v:
International journal of immunopharmacology. 13(2-3)
IL-2-PE40 is a chimeric cytotoxin composed of interleukin 2 (IL-2) fused to a truncated form of Pseudomonas exotoxin (PE) that lacks its binding domain. IL-2-PE40 has been shown to exhibit therapeutic potency in several models in vivo when administer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d70ec70c8dfa6e0ef6f98ffddd07b4a
https://pubmed.ncbi.nlm.nih.gov/2071302
https://pubmed.ncbi.nlm.nih.gov/2071302
Autor:
H, Lorberboum-Galski, R J, Garsia, M, Gately, P S, Brown, R E, Clark, T A, Waldmann, V K, Chaudhary, D J, FitzGerald, I, Pastan
Publikováno v:
The Journal of biological chemistry. 265(27)
To produce a molecule that will kill activated T cells as well as lymphomas and leukemias expressing interleukin 2 (IL2) receptors, we have created a recombinant chimeric protein in which IL2 is attached in peptide linkage to a truncated mutant form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::94799cdca86717bed2c421be3fc320ba
https://pubmed.ncbi.nlm.nih.gov/1975810
https://pubmed.ncbi.nlm.nih.gov/1975810
Autor:
S. Yarkoni, H. Lorberboum-Galski
Publikováno v:
JNCI Journal of the National Cancer Institute. 89:94-95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adad299e03d9312dfb787a793ce17682
https://doi.org/10.1093/jnci/89.1.94
https://doi.org/10.1093/jnci/89.1.94
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.